Kaiser, Larry R.

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research

Immune cells in cancerImmunotherapy and Immune Responses

Cited by 1,054

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Suzuki, E., Kapoor, V., Cheung, H.-K., Ling, L. E., DeLong, P. A., Kaiser, L. R., & Albelda, S. M. (2004) · Clinical Cancer Research

TGF-β signaling in diseasesOccupational and environmental lung diseases

Cited by 65

Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease

Bavaria, J. E., Pochettino, A., Kotloff, R. M., Rosengard, B. R., Wahl, P. M., Roberts, J., Palevsky, H. I., & Kaiser, L. R. (1998) · The Journal of Thoracic and Cardiovascular Surgery

Transplantation: Methods and OutcomesChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 39